Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Echinocandin for Severe Pneumocystis Jirovecii Pneumonia
NCT07900373Phase 3Not yet recruiting
- Sponsor
- McGill University Health Centre
- Start
- Apr 2027
- Primary completion
- Apr 2032
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pneumocystis jirovecii pneumonia (PJP) (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Hierarchical Composite Clinical Outcome Assessed Using the Win Odds/Win Ratio at 30 days. Planned start Apr 2027; status: not yet recruiting.
02
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT07900373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07900373.